TreeWAS – Variant ID: rs60037734

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E10 Insulin-dependent diabetes mellitus	0.126	0.874	0.000
E10.3 With ophthalmic complications	0.122	0.878	0.000
E10.9 Without complications	0.117	0.883	0.000
E10.1 With ketoacidosis	0.111	0.889	0.000
E10.2 With renal complications	0.107	0.893	0.000
E10.4 With neurological complications	0.106	0.894	0.000
E10.8 With unspecified complications	0.100	0.900	0.000
E10.5 With peripheral circulatory complications	0.099	0.901	0.000
E10.0 With coma	0.095	0.905	0.000
E10.7 With multiple complications	0.091	0.909	0.000
E10.6 With other specified complications	0.091	0.909	0.000
E10-E14 Diabetes mellitus	0.089	0.911	0.000
E14 Unspecified diabetes mellitus	0.073	0.927	0.000
E11 Non-insulin-dependent diabetes mellitus	0.070	0.930	0.000
E14.3 With ophthalmic complications	0.066	0.934	0.000
E13 Other specified diabetes mellitus	0.065	0.935	0.000
E12 Malnutrition-related diabetes mellitus	0.064	0.936	0.000
E11.8 With unspecified complications	0.059	0.941	0.000
E14.8 With unspecified complications	0.059	0.941	0.000
E11.1 With ketoacidosis	0.058	0.942	0.000
E11.0 With coma	0.057	0.943	0.000
E11.3 With ophthalmic complications	0.057	0.943	0.000
E11.5 With peripheral circulatory complications	0.056	0.944	0.000
E14.7 With multiple complications	0.052	0.948	0.000
E14.6 With other specified complications	0.052	0.948	0.000
E14.5 With peripheral circulatory complications	0.052	0.948	0.000
E14.4 With neurological complications	0.052	0.948	0.000
E14.2 Withrenal complications	0.052	0.948	0.000
E14.1 With ketoacidosis	0.052	0.948	0.000
E14.0 With coma	0.052	0.948	0.000
E11.6 With other specified complications	0.050	0.950	0.000
E11.7 With multiple complications	0.050	0.950	0.000
E11.2 With renal complications	0.048	0.952	0.000
E13.9 Without complications	0.047	0.953	0.000
E13.8 With unspecified complications	0.046	0.953	0.000
E13.7 With multiple complications	0.046	0.953	0.000
E13.6 With other specified complications	0.046	0.953	0.000
E13.5 With peripheral circulatory complications	0.046	0.953	0.000
E13.4 With neurological complications	0.046	0.953	0.000
E13.3 With ophthalmic complications	0.046	0.953	0.000
E13.2 With renal complications	0.046	0.953	0.000
E13.1 With ketoacidosis	0.046	0.953	0.000
E13.0 With coma	0.046	0.953	0.000
E12.9 Without complications	0.046	0.954	0.000
E12.8 With unspecified complications	0.046	0.954	0.000
E12.7 With multiple complications	0.046	0.954	0.000
E12.6 With other specified complications	0.046	0.954	0.000
E12.5 With peripheral circulatory complications	0.046	0.954	0.000
E12.4 With neurological complications	0.046	0.954	0.000
E12.3 With ophthalmic complications	0.046	0.954	0.000
E12.2 With renal complications	0.046	0.954	0.000
E12.1 With ketoacidosis	0.046	0.954	0.000
E12.0 With coma	0.046	0.954	0.000
E16.2 Hypoglycaemia, unspecified	0.038	0.962	0.000
E16 Other disorders of pancreatic internal secretion	0.036	0.964	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.034	0.966	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.034	0.966	0.000
Z85.8 Personal history of malignant neoplasms of other organs and systems	0.032	0.968	0.000
E11.4 With neurological complications	0.031	0.969	0.000
E40-E46 Malnutrition	0.030	0.970	0.000
E46 Unspecified protein-energy malnutrition	0.027	0.973	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.026	0.974	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.026	0.974	0.000
E16.4 Abnormal secretion of gastrin	0.026	0.974	0.000
E16.3 Increased secretion of glucagon	0.026	0.974	0.000
E16.1 Other hypoglycaemia	0.026	0.974	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.026	0.974	0.000
E15 Nondiabetic hypoglycaemic coma	0.025	0.975	0.000
E14.9 Without complications	0.024	0.976	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.021	0.978	0.000
E45 Retarded development following protein-energy malnutrition	0.021	0.978	0.000
E43 Unspecified severe protein-energy malnutrition	0.021	0.978	0.000
E42 Marasmic kwashiorkor	0.021	0.978	0.000
E41 Nutritional marasmus	0.021	0.978	0.000
E40 Kwashiorkor	0.021	0.978	0.000
E20-E35 Disorders of other endocrine glands	0.021	0.979	0.000
E50-E64 Other nutritional deficiencies	0.020	0.980	0.000
E65-E68 Obesity and other hyperalimentation	0.019	0.981	0.000
E27 Other disorders of adrenal gland	0.017	0.983	0.000
E34 Other endocrine disorders	0.017	0.983	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.017	0.983	0.000
E29 Testicular dysfunction	0.016	0.984	0.000
E24 Cushing's syndrome	0.016	0.984	0.000
E44.1 Mild protein-energy malnutrition	0.015	0.984	0.000
E44.0 Moderate protein-energy malnutrition	0.015	0.984	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.015	0.984	0.000
E32 Diseases of thymus	0.015	0.984	0.000
E31 Polyglandular dysfunction	0.015	0.984	0.000
E30 Disorders of puberty, not elsewhere classified	0.015	0.984	0.000
E25 Adrenogenital disorders	0.015	0.984	0.000
E20 Hypoparathyroidism	0.015	0.984	0.000
E21.3 Hyperparathyroidism, unspecified	0.015	0.985	0.000
E26 Hyperaldosteronism	0.015	0.985	0.000
E65 Localised adiposity	0.015	0.985	0.000
E34.8 Other specified endocrine disorders	0.015	0.985	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.014	0.985	0.000
E63 Other nutritional deficiencies	0.014	0.985	0.000
E56 Other vitamin deficiencies	0.014	0.985	0.000
E51 Thiamine deficiency	0.014	0.985	0.000
E50 Vitamin A deficiency	0.014	0.985	0.000
E60 Dietary zinc deficiency	0.014	0.985	0.000
E59 Dietary selenium deficiency	0.014	0.985	0.000
E58 Dietary calcium deficiency	0.014	0.985	0.000
E54 Ascorbic acid deficiency	0.014	0.985	0.000
E52 Niacin deficiency [pellagra]	0.014	0.985	0.000
E27.9 Disorder of adrenal gland, unspecified	0.014	0.986	0.000
E67 Other hyperalimentation	0.014	0.986	0.000
E68 Sequelae of hyperalimentation	0.014	0.986	0.000
E55 Vitamin D deficiency	0.014	0.986	0.000
E61 Deficiency of other nutrient elements	0.014	0.986	0.000
E00-E07 Disorders of thyroid gland	0.014	0.986	0.000
E27.8 Other specified disorders of adrenal gland	0.014	0.986	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.013	0.987	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.013	0.987	0.000
E27.5 Adrenomedullary hyperfunction	0.013	0.987	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.013	0.987	0.000
E27.2 Addisonian crisis	0.013	0.987	0.000
E27.0 Other adrenocortical overactivity	0.013	0.987	0.000
E23 Hypofunction and other disorders of pituitary gland	0.013	0.987	0.000
E53 Deficiency of other B group vitamins	0.013	0.987	0.000
E34.5 Androgen resistance syndrome	0.012	0.987	0.000
E34.4 Constitutional tall stature	0.012	0.987	0.000
E34.3 Short stature, not elsewhere classified	0.012	0.987	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.012	0.987	0.000
E34.1 Other hypersecretion of intestinal hormones	0.012	0.987	0.000
E28 Ovarian dysfunction	0.012	0.988	0.000
E27.1 Primary adrenocortical insufficiency	0.012	0.988	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.012	0.988	0.000
E21.4 Other specified disorders of parathyroid gland	0.012	0.988	0.000
E21.2 Other hyperparathyroidism	0.012	0.988	0.000
E29.1 Testicular hypofunction	0.012	0.988	0.000
E34.0 Carcinoid syndrome	0.012	0.988	0.000
E34.9 Endocrine disorder, unspecified	0.012	0.988	0.000
E04 Other non-toxic goitre	0.012	0.988	0.000
E29.9 Testicular dysfunction, unspecified	0.012	0.988	0.000
E29.8 Other testicular dysfunction	0.012	0.988	0.000
E29.0 Testicular hyperfunction	0.012	0.988	0.000
E24.9 Cushing's syndrome, unspecified	0.012	0.988	0.000
E24.8 Other Cushing's syndrome	0.011	0.988	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.011	0.988	0.000
E24.3 Ectopic ACTH syndrome	0.011	0.988	0.000
E24.2 Drug-induced Cushing's syndrome	0.011	0.988	0.000
E24.1 Nelson's syndrome	0.011	0.988	0.000
E24.0 Pituitary-dependent Cushing's disease	0.011	0.988	0.000
E22 Hyperfunction of pituitary gland	0.011	0.988	0.000
E04.9 Non-toxic goitre, unspecified	0.012	0.988	0.000
E20.9 Hypoparathyroidism, unspecified	0.011	0.989	0.000
E20.8 Other hypoparathyroidism	0.011	0.989	0.000
E20.1 Pseudohypoparathyroidism	0.011	0.989	0.000
E20.0 Idiopathic hypoparathyroidism	0.011	0.989	0.000
E25.9 Adrenogenital disorder, unspecified	0.011	0.989	0.000
E25.8 Other adrenogenital disorders	0.011	0.989	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.011	0.989	0.000
E30.9 Disorder of puberty, unspecified	0.011	0.989	0.000
E30.8 Other disorders of puberty	0.011	0.989	0.000
E30.1 Precocious puberty	0.011	0.989	0.000
E30.0 Delayed puberty	0.011	0.989	0.000
E31.9 Polyglandular dysfunction, unspecified	0.011	0.989	0.000
E31.8 Other polyglandular dysfunction	0.011	0.989	0.000
E31.1 Polyglandular hyperfunction	0.011	0.989	0.000
E31.0 Autoimmune polyglandular failure	0.011	0.989	0.000
E32.9 Disease of thymus, unspecified	0.011	0.989	0.000
E32.8 Other diseases of thymus	0.011	0.989	0.000
E32.1 Abscess of thymus	0.011	0.989	0.000
E32.0 Persistent hyperplasia of thymus	0.011	0.989	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.011	0.989	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.011	0.989	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.011	0.989	0.000
E26.9 Hyperaldosteronism, unspecified	0.011	0.989	0.000
E26.8 Other hyperaldosteronism	0.011	0.989	0.000
E26.1 Secondary hyperaldosteronism	0.011	0.989	0.000
E50.9 Vitamin A deficiency, unspecified	0.010	0.989	0.000
E50.8 Other manifestations of vitamin A deficiency	0.010	0.989	0.000
E50.7 Other ocular manifestations of vitamin A deficiency	0.010	0.989	0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.010	0.989	0.000
E50.5 Vitamin A deficiency with night blindness	0.010	0.989	0.000
E50.4 Vitamin A deficiency with keratomalacia	0.010	0.989	0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.010	0.989	0.000
E50.2 Vitamin A deficiency with corneal xerosis	0.010	0.989	0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.010	0.989	0.000
E50.0 Vitamin A deficiency with conjunctival xerosis	0.010	0.989	0.000
E51.9 Thiamine deficiency, unspecified	0.010	0.989	0.000
E51.8 Other manifestations of thiamine deficiency	0.010	0.989	0.000
E51.2 Wernicke's encephalopathy	0.010	0.989	0.000
E51.1 Beriberi	0.010	0.989	0.000
E56.9 Vitamin deficiency, unspecified	0.010	0.989	0.000
E56.8 Deficiency of other vitamins	0.010	0.989	0.000
E56.1 Deficiency of vitamin K	0.010	0.989	0.000
E56.0 Deficiency of vitamin E	0.010	0.989	0.000
E63.9 Nutritional deficiency, unspecified	0.010	0.989	0.000
E63.8 Other specified nutritional deficiencies	0.010	0.989	0.000
E63.1 Imbalance of constituents of food intake	0.010	0.989	0.000
E63.0 Essential fatty acid [EFA] deficiency	0.010	0.989	0.000
E64.9 Sequelae of unspecified nutritional deficiency	0.010	0.989	0.000
E64.8 Sequelae of other nutritional deficiencies	0.010	0.989	0.000
E64.3 Sequelae of rickets	0.010	0.989	0.000
E64.2 Sequelae of vitamin C deficiency	0.010	0.989	0.000
E64.1 Sequelae of vitamin A deficiency	0.010	0.989	0.000
E64.0 Sequelae of protein-energy malnutrition	0.010	0.989	0.000
E26.0 Primary hyperaldosteronism	0.010	0.989	0.000
E67.8 Other specified hyperalimentation	0.010	0.990	0.000
E67.3 Hypervitaminosis D	0.010	0.990	0.000
E67.2 Megavitamin-B6 syndrome	0.010	0.990	0.000
E67.1 Hypercarotenaemia	0.010	0.990	0.000
E67.0 Hypervitaminosis A	0.010	0.990	0.000
E55.0 Rickets, active	0.010	0.990	0.000
E61.9 Deficiency of nutrient element, unspecified	0.010	0.990	0.000
E61.8 Deficiency of other specified nutrient elements	0.010	0.990	0.000
E61.7 Deficiency of multiple nutrient elements	0.010	0.990	0.000
E61.6 Vanadium deficiency	0.010	0.990	0.000
E61.5 Molybdenum deficiency	0.010	0.990	0.000
E61.4 Chromium deficiency	0.010	0.990	0.000
E61.3 Manganese deficiency	0.010	0.990	0.000
E61.2 Magnesium deficiency	0.010	0.990	0.000
E61.0 Copper deficiency	0.010	0.990	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.010	0.990	0.000
E00 Congenital iodine-deficiency syndrome	0.010	0.990	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.010	0.990	0.000
E04.0 Non-toxic diffuse goitre	0.010	0.990	0.000
E23.7 Disorder of pituitary gland, unspecified	0.009	0.990	0.000
R26.8 Other and unspecified abnormalities of gait and mobility	0.010	0.990	0.000
E06 Thyroiditis	0.009	0.991	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.009	0.991	0.000
E23.1 Drug-induced hypopituitarism	0.009	0.991	0.000
E53.9 Vitamin B deficiency, unspecified	0.009	0.991	0.000
E53.1 Pyridoxine deficiency	0.009	0.991	0.000
E53.0 Riboflavin deficiency	0.009	0.991	0.000
N18.5 Chronic kidney disease, stage 5	0.009	0.991	0.000
E23.6 Other disorders of pituitary gland	0.009	0.991	0.000
E28.9 Ovarian dysfunction, unspecified	0.009	0.991	0.000
E28.8 Other ovarian dysfunction	0.009	0.991	0.000
E28.1 Androgen excess	0.009	0.991	0.000
E28.0 Oestrogen excess	0.009	0.991	0.000
R03.0 Elevated blood-pressure reading, without diagnosis of hypertension	0.009	0.991	0.000
E55.9 Vitamin D deficiency, unspecified	0.009	0.991	0.000
E61.1 Iron deficiency	0.009	0.991	0.000
N18.0 End-stage renal disease	0.009	0.991	0.000
E04.8 Other specified non-toxic goitre	0.009	0.991	0.000
E28.3 Primary ovarian failure	0.009	0.991	0.000
R26 Abnormalities of gait and mobility	0.009	0.991	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.008	0.991	0.000
E22.8 Other hyperfunction of pituitary gland	0.008	0.991	0.000
E07 Other disorders of thyroid	0.008	0.991	0.000
R26.2 Difficulty in walking, not elsewhere classified	0.008	0.992	0.000
N18 Chronic renal failure	0.008	0.992	0.000
E22.1 Hyperprolactinaemia	0.008	0.992	0.000
E23.2 Diabetes insipidus	0.008	0.992	0.000
R26.3 Immobility	0.008	0.992	0.000
K50.9 Crohn's disease, unspecified	0.000	0.992	0.008
E04.2 Non-toxic multinodular goitre	0.008	0.992	0.000
E23.0 Hypopituitarism	0.007	0.992	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.007	0.992	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.007	0.992	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.007	0.992	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.007	0.992	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.007	0.992	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.007	0.992	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.007	0.992	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.007	0.992	0.000
E04.1 Non-toxic single thyroid nodule	0.007	0.993	0.000
K50 Crohn's disease [regional enteritis]	0.000	0.993	0.007
E22.0 Acromegaly and pituitary gigantism	0.007	0.993	0.000
E53.8 Deficiency of other specified B group vitamins	0.007	0.993	0.000
K50.1 Crohn's disease of large intestine	0.000	0.993	0.007
N03.9 Unspecified	0.007	0.993	0.000
N18.1 Chronic kidney disease, stage 1	0.007	0.993	0.000
E06.5 Other chronic thyroiditis	0.007	0.993	0.000
E06.4 Drug-induced thyroiditis	0.007	0.993	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.007	0.993	0.000
E06.1 Subacute thyroiditis	0.007	0.993	0.000
E06.0 Acute thyroiditis	0.007	0.993	0.000
N18.2 Chronic kidney disease, stage 2	0.007	0.993	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.007	0.993	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.007	0.993	0.000
E21.0 Primary hyperparathyroidism	0.007	0.993	0.000
E06.3 Autoimmune thyroiditis	0.007	0.993	0.000
K50.8 Other Crohn's disease	0.000	0.993	0.007
E28.2 Polycystic ovarian syndrome	0.006	0.993	0.000
N18.9 Chronic renal failure, unspecified	0.007	0.993	0.000
N18.8 Other chronic renal failure	0.007	0.993	0.000
R26.1 Paralytic gait	0.006	0.994	0.000
E06.9 Thyroiditis, unspecified	0.006	0.994	0.000
E07.1 Dyshormogenetic goitre	0.006	0.994	0.000
E07.0 Hypersecretion of calcitonin	0.006	0.994	0.000
E07.8 Other specified disorders of thyroid	0.006	0.994	0.000
R26.0 Ataxic gait	0.006	0.994	0.000
K50.0 Crohn's disease of small intestine	0.000	0.994	0.006
E03 Other hypothyroidism	0.006	0.994	0.000
K70.9 Alcoholic liver disease, unspecified	0.006	0.994	0.000
E66 Obesity	0.005	0.995	0.000
K70 Alcoholic liver disease	0.005	0.995	0.000
M06.9 Rheumatoid arthritis, unspecified	0.005	0.995	0.000
M06.3 Rheumatoid nodule	0.005	0.995	0.000
E07.9 Disorder of thyroid, unspecified	0.005	0.995	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.005	0.995	0.000
M06.34 Rheumatoid nodule (Hand)	0.005	0.995	0.000
M06 Other rheumatoid arthritis	0.005	0.995	0.000
M06.0 Seronegative rheumatoid arthritis	0.005	0.995	0.000
H36.0 Diabetic retinopathy	0.005	0.995	0.000
K70.3 Alcoholic cirrhosis of liver	0.005	0.995	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.005	0.995	0.000
N18.4 Chronic kidney disease, stage 4	0.005	0.995	0.000
K70.4 Alcoholic hepatic failure	0.005	0.995	0.000
K70.1 Alcoholic hepatitis	0.005	0.995	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.005	0.995	0.000
E03.5 Myxoedema coma	0.004	0.995	0.000
E03.4 Atrophy of thyroid (acquired)	0.004	0.995	0.000
E03.3 Postinfectious hypothyroidism	0.004	0.995	0.000
E03.1 Congenital hypothyroidism without goitre	0.004	0.995	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.004	0.995	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.005	0.995	0.000
M06.37 Rheumatoid nodule (Ankle and foot)	0.004	0.996	0.000
R94.5 Abnormal results of liver function studies	0.004	0.996	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.004	0.996	0.000
E66.2 Extreme obesity with alveolar hypoventilation	0.004	0.996	0.000
Y48 Anaesthetics and therapeutic gases	0.004	0.996	0.000
E03.8 Other specified hypothyroidism	0.004	0.996	0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.004	0.996	0.000
D10.3 Other and unspecified parts of mouth	0.004	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.004	0.996	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.004	0.996	0.000
N03 Chronic nephritic syndrome	0.004	0.996	0.000
E66.1 Drug-induced obesity	0.004	0.996	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.004	0.996	0.000
S22.40 Multiple fractures of ribs (closed)	0.000	0.996	0.004
E66.0 Obesity due to excess calories	0.004	0.996	0.000
Y40 Systemic antibiotics	0.004	0.996	0.000
Y40.0 Penicillins	0.004	0.996	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.004	0.996	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.004	0.996	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.004	0.996	0.000
M06.39 Rheumatoid nodule (Site unspecified)	0.004	0.996	0.000
M06.38 Rheumatoid nodule (Other)	0.004	0.996	0.000
M06.36 Rheumatoid nodule (Lower leg)	0.004	0.996	0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.004	0.996	0.000
M06.33 Rheumatoid nodule (Forearm)	0.004	0.996	0.000
M06.32 Rheumatoid nodule (Upper arm)	0.004	0.996	0.000
M06.31 Rheumatoid nodule (Shoulder region)	0.004	0.996	0.000
M06.30 Rheumatoid nodule (Multiple sites)	0.004	0.996	0.000
Y48.3 Local anaesthetics	0.004	0.996	0.000
Y48.2 Other and unspecified general anaesthetics	0.004	0.996	0.000
Y57 Other and unspecified drugs and medicaments	0.004	0.996	0.000
D64.9 Anaemia, unspecified	0.004	0.996	0.000
M06.8 Other specified rheumatoid arthritis	0.004	0.996	0.000
M06.2 Rheumatoid bursitis	0.004	0.996	0.000
M06.1 Adult-onset Still's disease	0.004	0.996	0.000
M19.90 Arthrosis, unspecified (Multiple sites)	0.004	0.996	0.000
M06.08 Seronegative rheumatoid arthritis (Other)	0.004	0.996	0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.004	0.996	0.000
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.004	0.996	0.000
M06.04 Seronegative rheumatoid arthritis (Hand)	0.004	0.996	0.000
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.004	0.996	0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.004	0.996	0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.004	0.996	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.004	0.996	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
Y44 Agents primarily affecting blood constituents	0.004	0.996	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y57.9 Drug or medicament, unspecified	0.004	0.996	0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.004	0.996	0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.003	0.996	0.000
Y48.4 Anaesthetic, unspecified	0.004	0.996	0.000
J30.1 Allergic rhinitis due to pollen	0.000	0.996	0.004
G47.3 Sleep apnoea	0.004	0.996	0.000
E05.8 Other thyrotoxicosis	0.003	0.996	0.000
E05.5 Thyroid crisis or storm	0.003	0.996	0.000
E05.4 Thyrotoxicosis factitia	0.003	0.996	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.003	0.996	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.003	0.996	0.000
Y45.0 Opioids and related analgesics	0.004	0.996	0.000
Y52 Agents primarily affecting the cardiovascular system	0.004	0.996	0.000
M79.86 Other specified soft tissue disorders (Lower leg)	0.004	0.996	0.000
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.004	0.996	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
Y45.1 Salicylates	0.004	0.996	0.000
N17-N19 Renal failure	0.004	0.996	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.996	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.996	0.000
Y49.5 Other antipsychotics and neuroleptics	0.003	0.997	0.000
Y44.2 Anticoagulants	0.003	0.997	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.003	0.997	0.000
H66.9 Otitis media, unspecified	0.000	0.997	0.003
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
M06.4 Inflammatory polyarthropathy	0.003	0.997	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
N03.8 Other	0.003	0.997	0.000
N03.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N03.6 Dense deposit disease	0.003	0.997	0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N03.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
N03.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
N03.0 Minor glomerular abnormality	0.003	0.997	0.000
K72.9 Hepatic failure, unspecified	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
K72 Hepatic failure, not elsewhere classified	0.003	0.997	0.000
K70.0 Alcoholic fatty liver	0.003	0.997	0.000
Y40.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
Y40.6 Rifamycins	0.003	0.997	0.000
Y40.5 Aminoglycosides	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
Y40.3 Macrolides	0.003	0.997	0.000
Y40.2 Chloramphenicol group	0.003	0.997	0.000
K70-K77 Diseases of liver	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.003	0.997	0.000
Y45.8 Other analgesics and antipyretics	0.003	0.997	0.000
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
Y45.4 Antirheumatics	0.003	0.997	0.000
Y40.8 Other systemic antibiotics	0.003	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.6 Other diagnostic agents	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
Y57.5 X-ray contrast media	0.003	0.997	0.000
M06.19 Adult-onset Still's disease (Site unspecified)	0.003	0.997	0.000
M06.18 Adult-onset Still's disease (Other)	0.003	0.997	0.000
M06.17 Adult-onset Still's disease (Ankle and foot)	0.003	0.997	0.000
M06.16 Adult-onset Still's disease (Lower leg)	0.003	0.997	0.000
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.003	0.997	0.000
M06.14 Adult-onset Still's disease (Hand)	0.003	0.997	0.000
M06.13 Adult-onset Still's disease (Forearm)	0.003	0.997	0.000
M06.12 Adult-onset Still's disease (Upper arm)	0.003	0.997	0.000
M06.11 Adult-onset Still's disease (Shoulder region)	0.003	0.997	0.000
M06.10 Adult-onset Still's disease (Multiple sites)	0.003	0.997	0.000
M06.29 Rheumatoid bursitis (Site unspecified)	0.003	0.997	0.000
M06.28 Rheumatoid bursitis (Other)	0.003	0.997	0.000
M06.27 Rheumatoid bursitis (Ankle and foot)	0.003	0.997	0.000
M06.26 Rheumatoid bursitis (Lower leg)	0.003	0.997	0.000
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.003	0.997	0.000
M06.24 Rheumatoid bursitis (Hand)	0.003	0.997	0.000
M06.23 Rheumatoid bursitis (Forearm)	0.003	0.997	0.000
M06.22 Rheumatoid bursitis (Upper arm)	0.003	0.997	0.000
M06.21 Rheumatoid bursitis (Shoulder region)	0.003	0.997	0.000
M06.20 Rheumatoid bursitis (Multiple sites)	0.003	0.997	0.000
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.003	0.997	0.000
M06.88 Other specified rheumatoid arthritis (Other)	0.003	0.997	0.000
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.003	0.997	0.000
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.003	0.997	0.000
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.003	0.997	0.000
M06.84 Other specified rheumatoid arthritis (Hand)	0.003	0.997	0.000
M06.83 Other specified rheumatoid arthritis (Forearm)	0.003	0.997	0.000
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.003	0.997	0.000
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.003	0.997	0.000
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
Y57.8 Other drugs and medicaments	0.003	0.997	0.000
N19 Unspecified renal failure	0.003	0.997	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.003	0.997	0.000
Y44.7 Plasma substitutes	0.003	0.997	0.000
Y44.6 Natural blood and blood products	0.003	0.997	0.000
Y44.5 Thrombolytic drugs	0.003	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.003	0.997	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.003	0.997	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.003	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
K74 Fibrosis and cirrhosis of liver	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y45.2 Propionic acid derivatives	0.003	0.997	0.000
Y47.1 Benzodiazepines	0.003	0.997	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
Y51.0 Anticholinesterase agents	0.003	0.997	0.000
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
K73 Chronic hepatitis, not elsewhere classified	0.003	0.997	0.000
K73.9 Chronic hepatitis, unspecified	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations